Compared to newer options Retatrutide, the triple-agonist (GLP-1, GIP, and glucagon receptors), represents the next generation of incretin-based therapies
Some patients use extended protocols with physician oversight for complex healing challenges
When chased to a source, such figures generally attach to small studies, non-standard endpoints, or combination protocols (for example, a peptide paired with a photosensitizer or a procedure), and they do not represent GHK-Cu monotherapy in a rigorous trial
Follicles pushed from telogen into anagen must first shed their old hair before producing new growth
Record doses, timing, injection sites, subjective effects, measurable outcomes, and any side effects